Anogenital cancers are a group of human papillomavirus (HPV)-related cancers which include anal, cervical, penile, vaginal, and vulvar cancers. The Anogenital Cancers Program is a multi-disciplinary clinical and research team that employs the most advanced treatment approaches based on the latest research findings. Patients are seen at both the University of Washington Medical Center and the Seattle Cancer Care Alliance.
Our team of researchers has expertise in a wide range of fields from basic science and medicine, to global health and epidemiology and are working to improve prevention, detection, diagnosis and treatment for anogenital cancers. The program is interinstitutional bringing together doctors and investigators from Fred Hutch, UW Medicine and the University of Washington, Seattle Cancer Care Alliance, Seattle Children’s, and PATH.
Dr. Galloway studies the mechanisms by which human papillomaviruses contribute to cancer, with an emphasis on types most likely to progress to cervical cancer. They work to understand the natural history of genital HPV infections and why only a small subset of women infected with high-risk HPVs develop cancer.